⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Participants With Advanced Carcinoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Participants With Advanced Carcinoma

Official Title: A Phase 1/2 Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Patients With Advanced Carcinoma

Study ID: NCT00794417

Study Description

Brief Summary: The purpose of the study was to determine whether the combination of aflibercept, pemetrexed and cisplatin is safe and effective in treating non-small cell lung cancer (NSCLC).

Detailed Description: The study was conducted in two phases. In phase 1, patients with advanced cancer received different doses of aflibercept in combination with approved doses of pemetrexed and cisplatin. The objective of phase 1 was to determine the safest dose of the combined study medications. This dose was administered to patients with previously untreated NSCLC in phase 2. The phase 2 portion of the study determined if the combination is effective in treating NSCLC.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Arizona Cancer Institute, LLC, Tucson, Arizona, United States

University of Arkansas for Medical Science, Little Rock, Arkansas, United States

Stanford University Medical Center, Stanford, California, United States

Palm Beach Institute of Hematology and Oncology, Boynton Beach, Florida, United States

Edward Hines Jr. VA Medical Center, Hines, Illinois, United States

Kentucky Cancer Clinic, Hazard, Kentucky, United States

Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States

Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

UNM Cancer Clinic, Albuquerque, New Mexico, United States

Montefiore Medical Center, Bronx, New York, United States

Roswell Park Cancer Institute, Buffalo, New York, United States

Presbyterian Hospital Center for Cancer Research, Charlotte, North Carolina, United States

Erie Regional Cancer Center, Erie, Pennsylvania, United States

Schiffler Cancer Center - Medical Oncology Division, Wheeling, West Virginia, United States

Princess Margaret Hospital, Toronto, Ontario, Canada

Contact Details

Name: Clinical Trial Management

Affiliation: Regeneron Pharmaceuticals

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: